PACIRA BIOSCIENCES, INC. Inventory, Work in Process, Net of Reserves
PACIRA BIOSCIENCES, INC. (PCRX) had Inventory, Work in Process, Net of Reserves of $38.10 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryWorkInProcessNetOfReserves · last filed 2026-08-04
- 2026-06-30: Inventory, Work in Process, Net of Reserves $38.10M.
- 2026-03-31: Inventory, Work in Process, Net of Reserves $39.88M.
- 2025-12-31: Inventory, Work in Process, Net of Reserves $28.20M.
- 2025-09-30: Inventory, Work in Process, Net of Reserves $18.84M.
| Period end | Inventory, Work in Process, Net of Reserves |
|---|---|
| 2026-06-30 | $38.10M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $39.88M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $28.20M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $18.84M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $11.08M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $32.28M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $27.38M 10-K · filed 2026-02-26 |
| 2024-09-30 | $23.10M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $23.65M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $18.76M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $31.21M 10-K · filed 2025-02-27 |
| 2023-09-30 | $23.77M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $27.70M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $34.94M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $28.85M 10-K · filed 2024-02-29 |
| 2022-09-30 | $35.03M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $39.41M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $33.99M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $35.18M 10-K · filed 2023-02-28 |
| 2021-09-30 | $17.22M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $14.40M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $10.04M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $16.27M 10-K · filed 2022-02-28 |
| 2020-09-30 | $12.08M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $9.70M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $7.76M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $14.41M 10-K · filed 2021-03-01 |
| 2019-09-30 | $17.47M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $10.98M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $11.14M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $9.71M 10-K · filed 2020-02-21 |
| 2018-09-30 | $12.01M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $7.33M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $8.43M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $8.37M 10-K · filed 2019-02-28 |
| 2017-09-30 | $9.01M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $6.21M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $7.71M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $11.62M 10-K · filed 2018-02-28 |
| 2016-09-30 | $11.44M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $1.97M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $9.94M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $12.15M 10-K · filed 2017-03-01 |
| 2015-09-30 | $8.87M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $13.85M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $12.51M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $8.62M 10-K · filed 2016-02-25 |
| 2014-09-30 | $10.40M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $5.47M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $7.76M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $6.32M 10-K · filed 2015-02-24 |
| 2013-09-30 | $6.95M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $6.53M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $4.24M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $5.98M 10-K · filed 2014-02-25 |
| 2012-09-30 | $1.03M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $1.43M 10-Q · filed 2012-08-09 |
| 2011-12-31 | $96.00K 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |